Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Pancreatic Cancer”

227 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 227 results

Testing effectiveness (Phase 2)WithdrawnNCT00728000
What this trial is testing

Phase II Study Of Neoadjuvant Chemotherapy In Borderline Resectable Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Cincinnati
Not applicableLooking for participantsNCT05052671
What this trial is testing

CtDNA Assay in Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreas Cancer
University of Oklahoma 50
Early research (Phase 1)Looking for participantsNCT06673017
What this trial is testing

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal AdenocarcinomaBorderline Resectable Pancreatic AdenocarcinomaLocally Advanced Pancreatic Adenocarcinoma+1 more
PanTher Therapeutics 26
Not applicableUnknownNCT05848154
What this trial is testing

Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer

Who this might be right for
Patients With Non-metastatic Pancreatic CancerEvaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
Shanghai Zhongshan Hospital 92
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06234072
What this trial is testing

Comparing Astragalus Plus Gemcitabine to Gemcitabine Alone as Neoadjuvant Treatment for Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
Shenzhen University General Hospital 120
Early research (Phase 1)Not Yet RecruitingNCT06346808
What this trial is testing

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

Who this might be right for
Pancreatic Cancer
Sichuan University 20
Not applicableLooking for participantsNCT07651358
What this trial is testing

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Stage I Pancreatic Cancer AJCC v8Stage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8
OHSU Knight Cancer Institute 30
Early research (Phase 1)Looking for participantsNCT07024615
What this trial is testing

ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Astellas Pharma Global Development, Inc. 25
Large-scale testing (Phase 3)UnknownNCT04617821
What this trial is testing

AG vs mFOLFIRINOX as Neoadjuvant Therapy for Borderline Reseactable and Locally Advanced Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma
Fudan University 300
Testing effectiveness (Phase 2)Study completedNCT02125136
What this trial is testing

Trial to Investigate Intensified Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Ductal Adenocarcinoma of the Pancreas
AIO-Studien-gGmbH 168
Early research (Phase 1)Ended earlyNCT00892242
What this trial is testing

Perioperative Treatment With Zoledronic Acid in Patients With Resectable Pancreas Cancer

Who this might be right for
Adenocarcinoma
Washington University School of Medicine 24
Early research (Phase 1)UnknownNCT02506803
What this trial is testing

Phase I Study of Neoadjuvant Chemotherapy for Patients With Borderline Resectable Pancreatic Cancer.

Who this might be right for
Pancreatic Cancer
Wakayama Medical University 10
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Testing effectiveness (Phase 2)Study completedNCT01470417
What this trial is testing

Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
University of Florida 10
Not applicableStudy completedNCT02680990
What this trial is testing

Resilience and Exercise in Advanced Cancer Treatment

Who this might be right for
Pancreatic AdenocarcinomaGastric AdenocarcinomaAdenocarcinoma of the Gastroesophageal Junction
Milton S. Hershey Medical Center 14
Large-scale testing (Phase 3)UnknownNCT05181605
What this trial is testing

Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Cancer Resectable
Instituto de investigación e innovación biomédica de Cádiz 116
Large-scale testing (Phase 3)Looking for participantsNCT07081360
What this trial is testing

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

Who this might be right for
Pancreas CancerPeriampullary CancerPeriampullary Carcinoma Resectable+3 more
Minia University 262
Not applicableActive Not RecruitingNCT04423731
What this trial is testing

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaChemotherapy EffectBorderline Resectable Pancreatic Adenocarcinoma+1 more
Oslo University Hospital 251
Not applicableUnknownNCT03009253
What this trial is testing

Translational Research on Locally Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Not applicableStudy completedNCT01442974
What this trial is testing

Assessment Of Stromal Response To Nab-Paclitaxel In Combination With Gemcitabine In Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Grupo Hospital de Madrid 15
Next Page